NG

Nabnita Giri

Active Director Director DIN 08784560
DIN 08784560 First appointment Jul 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2020
Shareholding value •••• Premium profile

About Nabnita Giri

Data last updated:

Nabnita Giri is a Director at Brisk Pharmaceuticals Private Limited (since 2020). The company operates in Pharma. Brisk Pharmaceuticals Private Limited reported revenue of ₹39.1 Lakh (FY 2021).

DIN 08784560
Primary Designation Director
Industry Pharma
First Appointment 07 Jul 2020
Oldest Company Age 6 yrs
Largest company Brisk Pharmaceuticals Private Limited · ₹39.1 Lakh (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Jul 20202020₹39.1 Lakh (FY 2021)Active

Board colleagues of Nabnita Giri

NameDINCompanyDesignation
Partha Pratim Giri08784559Brisk Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Brisk Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Nabnita Giri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nabnita Giri

Nabnita Giri currently holds 1 directorship: Brisk Pharmaceuticals Private Limited (Director, since 07 Jul 2020, revenue ₹39.1 Lakh (FY 2021)).

Nabnita Giri was first appointed on 07 Jul 2020 as Director at Brisk Pharmaceuticals Private Limited.

The current boards of Nabnita Giri's companies include Partha Pratim Giri (Brisk Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available